Showing results (181-190 of 696) with videos related to
Sort By:
Pageof 70
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 26, 2015
Diagnosis and treatment of early renal disease in patients with type 2 diabetes mellitus: what are the clinical needs?Johannes F E Mann, Peter Rossing, Andrzej Wiȩcek, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 25, 2003
Time course of the antiproteinuric and antihypertensive effect of losartan in diabetic nephropathySteen Andersen, Peter Jacobsen, Lise Tarnow, et al.Journal of Market Access & Health Policy|August 28, 2024
Comparative Efficacy of Finerenone versus Canagliflozin in Patients with Chronic Kidney Disease and Type 2 Diabetes: A Matching-Adjusted Indirect ComparisonDavid Cherney, Kerstin Folkerts, Paul Mernagh, et al.Diabetes Research and Clinical Practice|June 11, 2022
Association between plasma apolipoprotein M and cardiac autonomic neuropathy in type 1 diabetesMostafa Safi, Anna Borup, Christian Stevns Hansen, et al.Nephron. Clinical Practice|December 17, 2010
Urinary neutrophil gelatinase-associated lipocalin and progression of diabetic nephropathy in type 1 diabetic patients in a four-year follow-up studyStine Elkjaer Nielsen, Henrik Post Hansen, Berit Ruud Jensen, et al.Proteomics. Clinical Applications|December 8, 2010
The urinary proteome in diabetes and diabetes-associated complications: New ways to assess disease progression and evaluate therapyKasper Rossing, Harald Mischak, Peter Rossing, et al.Kidney International|January 29, 2011
Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathyStine E Nielsen, Steen Andersen, Dietmar Zdunek, et al.Current Pharmaceutical Design|June 24, 2017
Trimethylamine N-oxide (TMAO) as a New Potential Therapeutic Target for Insulin Resistance and CancerJens Oellgaard, Signe Abitz Winther, Tobias Schmidt Hansen, et al.British Journal of Clinical Pharmacology|April 16, 2015
The renal protective effect of angiotensin receptor blockers depends on intra-individual response variation in multiple risk markersBauke Schievink, Dick de Zeeuw, Hans-Henrik Parving, et al.Diabetic Medicine : a Journal of the British Diabetic Association|July 6, 2021
Urinary peptidome and diabetic retinopathy in the DIRECT-Protect 1 and 2 trialsViktor Rotbain Curovic, Pedro Magalhães, Tianlin He, et al.Pageof 70